Provided by Tiger Trade Technology Pte. Ltd.

Akari Therapeutics PLC

8.77
+0.64007.87%
Volume:76.45K
Turnover:649.83K
Market Cap:20.04M
PE:-0.55
High:8.97
Open:8.51
Low:8.20
Close:8.13
52wk High:40.00
52wk Low:3.02
Shares:2.29M
Float Shares:1.71M
Volume Ratio:2.75
T/O Rate:4.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-15.9015
EPS(LYR):-20.5537
ROE:-140.09%
ROA:-19.10%
PB:1.08
PE(LYR):-0.43

Loading ...

Akari Therapeutics wins European patent for thailanstatin-based ADC payloads

Reuters
·
May 12

Akari Therapeutics Plc - Aktx-101 Phase 1 First-in-Human Trial Targeted by Mid-2027

THOMSON REUTERS
·
May 12

Akari Therapeutics Plc - Granted Major European Patent for Ph1 ADC Payload Platform

THOMSON REUTERS
·
May 12

ADRs Close Lower; Akari Therapeutics PLC Declines 18%

Dow Jones
·
May 12

European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading

MT Newswires Live
·
May 11

Akari Therapeutics PLC expected to post a loss of $1.38 a share - Earnings Preview

Reuters
·
May 09

European Equities Traded in the US as American Depositary Receipts Climb Sharply Higher in Wednesday Trading

MT Newswires Live
·
May 06

European Equities Traded in the US as American Depositary Receipts Start Week Lower

MT Newswires Live
·
May 04

European Equities Traded in the US as American Depositary Receipts Flat in Friday Trading; Gain 1.3% for Week

MT Newswires Live
·
May 01

European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading

MT Newswires Live
·
Apr 29

European Equities Traded in the US as American Depositary Receipts Track Lower in Monday Trading

MT Newswires Live
·
Apr 27

BRIEF-Akari Therapeutics Secures Australian Patent Approval

Reuters
·
Apr 27

Akari Therapeutics wins Australian patent acceptance for Thailanstatin analog ADC payload

Reuters
·
Apr 27

Akari Therapeutics Plc - Aktx-101 in Ind-Enabling Studies With Phase 1 Trial Expected Late 2026/Early 2027

THOMSON REUTERS
·
Apr 27

Akari Therapeutics Secures Australian Patent Approval, Further Expanding Global Protection of Its Proprietary Ph1 Rna Splicing Modulator ADC Payload

THOMSON REUTERS
·
Apr 27

European Equities Traded in US as ADRs Ease in Thursday Trading

MT Newswires Live
·
Apr 23

European Equities Traded in the US as American Depositary Receipts Sharply Lower in Tuesday Trading

MT Newswires Live
·
Apr 21

Akari Therapeutics ASCO Abstract Acceptance Highlights Potential for AKTX-101 ADC to Treat KRAS Mutant Tumors

GlobeNewswire
·
Apr 21

European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading

MT Newswires Live
·
Apr 20

Akari Therapeutics announces presentation of preclinical data for AKTX-101

TIPRANKS
·
Apr 20